IT8267464A0 - Composti cefalosporinici particolarmente per la cura delle affezioni da batteri gram positivi e gramnegativi composizioni farmaceutiche che li contengono e procedimento per la loro fabbricazione - Google Patents

Composti cefalosporinici particolarmente per la cura delle affezioni da batteri gram positivi e gramnegativi composizioni farmaceutiche che li contengono e procedimento per la loro fabbricazione

Info

Publication number
IT8267464A0
IT8267464A0 IT8267464A IT6746482A IT8267464A0 IT 8267464 A0 IT8267464 A0 IT 8267464A0 IT 8267464 A IT8267464 A IT 8267464A IT 6746482 A IT6746482 A IT 6746482A IT 8267464 A0 IT8267464 A0 IT 8267464A0
Authority
IT
Italy
Prior art keywords
gram
procedure
positive
contain
manufacturing
Prior art date
Application number
IT8267464A
Other languages
English (en)
Other versions
IT1207341B (it
Inventor
Nagano Kohji Nakano Noriaki
Shibanuma Tadao
Murakami Yukiyasu
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of IT8267464A0 publication Critical patent/IT8267464A0/it
Application granted granted Critical
Publication of IT1207341B publication Critical patent/IT1207341B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT8267464A 1981-04-09 1982-04-07 Composti cefalosporinici particolarmente per la cura delle affezioni da batteri gram positivi e gramnegativi composizioni farmaceutiche che li contengono e procedimento per la loro fabbricazione IT1207341B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56052408A JPS6011917B2 (ja) 1981-04-09 1981-04-09 新規なセファロスポリン化合物

Publications (2)

Publication Number Publication Date
IT8267464A0 true IT8267464A0 (it) 1982-04-07
IT1207341B IT1207341B (it) 1989-05-17

Family

ID=12913956

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8267464A IT1207341B (it) 1981-04-09 1982-04-07 Composti cefalosporinici particolarmente per la cura delle affezioni da batteri gram positivi e gramnegativi composizioni farmaceutiche che li contengono e procedimento per la loro fabbricazione

Country Status (6)

Country Link
US (1) US4474779A (it)
JP (1) JPS6011917B2 (it)
DE (2) DE3249832C2 (it)
FR (1) FR2503712A1 (it)
GB (1) GB2104888B (it)
IT (1) IT1207341B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616081A (en) * 1982-07-07 1986-10-07 Asahi Kasei Kogyo Kabushiki Kaisha Cephalosporin compounds
DK96284A (da) * 1983-03-04 1984-09-05 Fujisawa Pharmaceutical Co Cephemderivater
JPS6041683A (ja) * 1983-07-06 1985-03-05 Asahi Chem Ind Co Ltd 経口用セフアロスボリン誘導体
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4695565A (en) * 1984-10-04 1987-09-22 Merck & Co., Inc. Antibacterial 7β-heterocyclic-cephem
EP0182633A3 (en) * 1984-11-20 1987-09-02 Ici Pharma Cephalosporin derivatives
ATE177104T1 (de) * 1984-11-23 1999-03-15 Biochemie Gmbh Cephalosporinderivative
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
IL83993A0 (en) * 1986-09-26 1988-02-29 Glaxo Group Ltd Cephalosporins,their preparation and pharmaceutical compositions containing them
GB8623211D0 (en) * 1986-09-26 1986-10-29 Glaxo Group Ltd Chemical compounds
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
GB8704621D0 (en) * 1987-02-27 1987-04-01 Glaxo Group Ltd Chemical compounds
JPH0320265A (ja) * 1989-02-10 1991-01-29 Meiji Seika Kaisha Ltd アミノチアゾール酢酸誘導体並びにその製造法
JPH11124384A (ja) * 1997-10-17 1999-05-11 Otsuka Chem Co Ltd ３−セフェム化合物の製造法
SI1699804T1 (sl) * 2003-12-23 2008-08-31 Sandoz Ag Postopek za pripravo intermediatov za uporabo pri sintezi cefalosporinov
PT3616695T (pt) 2011-09-09 2024-11-18 Merck Sharp & Dohme Ceftolozano/tazobactam para tratar infeções intrapulmonares
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
JP2014165096A (ja) * 2013-02-27 2014-09-08 Nippon Zeon Co Ltd リチウムイオン二次電池耐熱層用スラリーの製造方法及びリチウムイオン二次電池用電極の製造方法
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
PE20160048A1 (es) 2013-03-15 2016-02-12 Merck Sharp & Dohme Composiciones antibioticas de ceftolozano
US20140274996A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Tazobactam and ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
BE878433A (fr) * 1978-08-31 1980-02-25 Fujisawa Pharmaceutical Co Procede de preparation de derives d'acide 3-cephem-4-carboxylique 3,7-disubstitue, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
JPS52125188A (en) * 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
DE2824559C2 (de) * 1977-06-10 1985-01-10 Yamanouchi Pharmaceutical Co., Ltd., Tokio / Tokyo 7α-Methoxy-7β-(4-substituierte-methylen-1,3-dithietan-2-yl)-carboxamido-3-Δ↑3↑-cephem-4-carbonsäuren, Verfahren zu deren Herstellung sowie ihre Verwendung
GB2027691B (en) * 1978-05-26 1983-03-02 Glaxo Group Ltd Cephalosporin antibiotics
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
BE878637A (fr) * 1978-09-11 1980-03-06 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3-cephem-4-carboxylique 3,7-disubstitue et de leurs sels pharmaceutiquement acceptables, nouveaux produits ainsi obtenus et leur utilisation pour leurs activites antimicrobiennes

Also Published As

Publication number Publication date
FR2503712B1 (it) 1985-02-22
DE3212900A1 (de) 1982-11-25
DE3249832C2 (it) 1988-12-29
GB2104888B (en) 1984-12-19
FR2503712A1 (fr) 1982-10-15
JPS6011917B2 (ja) 1985-03-28
JPS57167992A (en) 1982-10-16
IT1207341B (it) 1989-05-17
DE3212900C2 (it) 1988-04-14
GB2104888A (en) 1983-03-16
US4474779A (en) 1984-10-02

Similar Documents

Publication Publication Date Title
IT1207341B (it) Composti cefalosporinici particolarmente per la cura delle affezioni da batteri gram positivi e gramnegativi composizioni farmaceutiche che li contengono e procedimento per la loro fabbricazione
IT1210589B (it) Procedimento per la preparazione dicomposti pirimidinici dotati di attivita' farmacologica particolarmente per il trattamento di infezioni batteriche loro intermedi prodotto ottenuto e composizioni farmaceutiche che li contengono
NO169637C (no) Fremgangsmaate for fremstilling av terapeutisk aktive hyaluronsyre-fraksjoner
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
ZA841373B (en) Quinolonecarboxylic acids,processes for their preparation and antibacterial agents containing these compounds
DE3369508D1 (en) Triphenylimidazolyloxyalcanoic acids and their derivatives, process for their preparation and pharmaceutical compositions containing them
DE3377063D1 (en) Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
IT8348006A0 (it) Loro produzione derivati cefalosporinici e composizioni antibatteriche che li contengono, nonche' procedimento per la
NO157819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo (1,2-a)-pyridin-2-yl-karbostyrilforbindelser.
DE2963572D1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
SE8406201L (sv) Penicillansyraderivat
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
PT73283A (fr) Procede de preparation d'oxides de cephalosporines
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
NO171502C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive thiadiazolylacetamidcefem-derivater
SE8009049L (sv) 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
ATE75746T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung.
IL71712A0 (en) Pharmaceutical compositions for the treatment and prophylaxis of infections and obstructive respiratory tract diseases and their preparation
IT7867986A0 (it) Cefalosporine ad azione antibatterica procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IL60123A0 (en) Pharmaceutical composition for the treatment of bactericidal infections of the urinary and genital tracts
IT8267577A0 (it) Composti del beta lattame composizioni farmaceutiche che li contengono e procedimento per la loro preparazione